Eagle Materials Inc. has announced its financial results for the second quarter of fiscal 2027, revealing record revenue and solid earnings despite ongoing challenges in the construction industry.
On November 4, 2026, the company reported revenue of $652.7 million for the quarter ending September 30, 2026, marking a significant achievement for the firm. This revenue reflects a robust performance in the face of elevated diesel fuel prices and higher interest rates, which have created a challenging operating environment.
Company Overview
Eagle Materials Inc., incorporated in Delaware, is a leading supplier of construction materials, primarily engaged in the production of hydraulic cement and other building materials. The company trades on the New York Stock Exchange under the ticker symbol EXP and is classified under the SIC code 3241, which pertains to cement manufacturing.
What the Filing Says
The SEC filing reveals key financial highlights for the quarter. Notable figures include:
- Record revenue of $652.7 million
- Net earnings of $111.5 million
- Net earnings per diluted share of $3.63
- Adjusted EBITDA of $202.7 million
- Repurchased 304,881 shares of common stock for approximately $62 million
Michael Haack, President and CEO, commented on the results, stating, “Eagle’s businesses continued to perform well during the quarter despite a challenging operating environment characterized by elevated diesel fuel prices and higher interest rates driven by ongoing macroeconomic and geopolitical uncertainty.”
Impact
The results may influence various stakeholders, including investors, employees, and customers. Eagle's strong financial performance indicates its resilience and ability to navigate market challenges, which could enhance investor confidence. The construction sector, which includes competitors in the hydraulic cement space, may also take note of Eagle’s strategies and performance as they navigate similar economic pressures.
What's Next
The filing does not specify what happens next, but the company’s ongoing focus on operational efficiency and strategic investments suggests that it will continue to adapt to the evolving market conditions.
Read Next
Viridian Therapeutics reports Q3 2026 financial results
Dine Brands reports strong Q3 results, boosts revenue outlook
Rapport Therapeutics releases Q3 results, highlights growth
Latham Group Reports Strong Q3 Results, Signals Growth Ahead
Vishay Intertechnology reports quarterly results for Q3 2026
Riot Platforms terminates custodial agreement with NYDIG Trust




